Future studies are warranted to confirm the differences in the extent of SOX4 gene expression between ATLL and PTCL-NOS, and to investigate whether there are any correlations between the intensity of SOX4 expression in tumor cells and the clinical prognosis of ATLL patients. This evidence concerns the gene SOX4 and neoplasm.